MM-613 Healthcare Resource Utilization and Costs Among Patients With Relapsed/Refractory Multiple Myeloma Treated With Chimeric Antigen Receptor-T (CAR-T) Cell Therapy

Autor: Jagannath, Sundar, Kharat, Akshay, Fu, Alex, Huo, Stephen, Kohli, Monal, Adams, Shayna, Umeh, Emeka, Foster, Miran
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S511-S512
Databáze: ScienceDirect